There was no significant difference (p-value >0.05) between PRUNE2 expression levels between the different tumor stages: pT2 (median: 11.4; IQR: 10.7–12.1), pT3 (median: 11.3; IQR: 10.6–12.0), and pT4 (median: 11.7; IQR: 10.8–12.1). This evidence concerns the gene PRUNE2 and neoplasm.